The phosphorylation level of SMAD1/5 was higher in the hDPSCs treated with the two recombinant biofactors than in the cells treated with BMP2 alone, and was positively relevant to the dose of OMD with the existence of BMP2 (Fig. 4C). This evidence concerns the gene BMP2 and occult macular dystrophy.